Meredith Cook Biography and Net Worth

Senior Vice President, General Counsel and Corporate Secretary of ANI Pharmaceuticals

Ms. Cook is ANI’s Senior Vice President, General Counsel and Corporate Secretary. Ms. Cook joined ANI in July 2022 and brings over 20 years of experience to the role. Prior to joining ANI, Ms. Cook served as Vice President and Associate General Counsel for Amneal Pharmaceuticals, Inc., where she was responsible for corporate and strategic transactions across all business units, with additional responsibilities related to corporate governance, commercial contracts, employment matters, and IP. Prior to Amneal Pharmaceuticals, Ms. Cook served as Global Legal Head, M&A, Business Development and Strategic Transactions for Dr. Reddy’s Laboratories, Inc. She was previously with Morgan, Lewis & Bockius, LLP and Vinson & Elkins, LLP, where she represented clients in a variety of industries, including in the pharmaceutical and life sciences space. Ms. Cook earned her bachelor’s degree in East Asian Studies from Princeton University and her Juris Doctorate from Tulane Law School.

What is Meredith Cook's net worth?: The estimated net worth of Meredith Cook is at least $5.55 million as of April 14th, 2025. Ms. Cook owns 80,145 shares of ANI Pharmaceuticals stock worth more than $5,546,835 as of April 17th. This net worth approximation does not reflect any other assets that Ms. Cook may own. Learn More about Meredith Cook's net worth.
How old is Meredith Cook?: Ms. Cook is currently 49 years old. There are 7 older executives and no younger executives at ANI Pharmaceuticals. The oldest executive at ANI Pharmaceuticals is Mr. James G. Marken, Senior Vice President of Operations, who is 61 years old. Learn More on Meredith Cook's age.
How do I contact Meredith Cook?: The corporate mailing address for Ms. Cook and other ANI Pharmaceuticals executives is 210 Main Street West, Baudette MN, 56623. ANI Pharmaceuticals can also be reached via phone at (218) 634-3500 and via email at [email protected]. Learn More on Meredith Cook's contact information.
Has Meredith Cook been buying or selling shares of ANI Pharmaceuticals?: During the past quarter, Meredith Cook has sold $27,584.00 of ANI Pharmaceuticals stock. Most recently, Meredith Cook sold 400 shares of the business's stock in a transaction on Monday, April 14th. The shares were sold at an average price of $68.96, for a transaction totalling $27,584.00. Following the completion of the sale, the vice president now directly owns 80,145 shares of the company's stock, valued at $5,526,799.20. Learn More on Meredith Cook's trading history.
Who are ANI Pharmaceuticals' active insiders?: ANI Pharmaceuticals' insider roster includes Stephen Carey (CFO), Stephen Carey (Senior Vice President, Finance and Chief Financial Officer), Meredith Cook (Senior Vice President, General Counsel and Corporate Secretary), Krista Davis (Senior Vice President and Chief Human Resources Officer), Chad Gassert (Senior Vice President, Corporate Development and Strategy), Ori Gutwerg (Senior Vice President, Generics), Thomas Haughey (Director), Nikhil Lalwani (Pres), Nikhil Lalwani (President and Chief Executive Officer), James Marken (Senior Vice President, Operations and Product Development), Christopher Mutz (Insider), Antonio Pera (Director), Muthusamy Shanmugam (Head of R&D and COO of NJ Operations), Muthusamy Shanmugam (Head of R&D and COO), Renee Tannenbaum (Director), Jeanne Thoma (Director), and Patrick Walsh (Director). Learn More on ANI Pharmaceuticals' active insiders.
Are insiders buying or selling shares of ANI Pharmaceuticals?: During the last year, insiders at the specialty pharmaceutical company sold shares 31 times. They sold a total of 240,862 shares worth more than $15,120,580.03. The most recent insider tranaction occured on April, 14th when VP Meredith Cook sold 400 shares worth more than $27,584.00. Insiders at ANI Pharmaceuticals own 12.7% of the company. Learn More about insider trades at ANI Pharmaceuticals.
Information on this page was last updated on 4/14/2025.

Meredith Cook Insider Trading History at ANI Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/14/2025	Sell	400	$68.96	$27,584.00	80,145
3/13/2025	Sell	400	$63.33	$25,332.00	80,545
2/13/2025	Sell	400	$59.54	$23,816.00	83,478
1/13/2025	Sell	400	$53.92	$21,568.00	55,588
10/14/2024	Sell	250	$57.19	$14,297.50	56,488
9/13/2024	Sell	250	$56.82	$14,205.00	56,738
8/13/2024	Sell	250	$59.62	$14,905.00	56,988
7/12/2024	Sell	250	$64.91	$16,227.50	58,981
6/13/2024	Sell	250	$63.80	$15,950.00	59,231
5/13/2024	Sell	250	$67.69	$16,922.50	59,481
4/12/2024	Sell	250	$67.79	$16,947.50	59,731
2/13/2024	Sell	250	$56.04	$14,010.00	36,799
1/12/2024	Sell	250	$56.43	$14,107.50	37,049
12/11/2023	Sell	250	$49.21	$12,302.50	37,299

Meredith Cook Buying and Selling Activity at ANI Pharmaceuticals

ANI Pharmaceuticals Company Overview

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Today's Range

Now: $69.21

$68.64

$70.48

50 Day Range

MA: $63.07

$54.51

$69.55

2 Week Range

Now: $69.21

$52.50

$70.48

Volume

299,660 shs

Average Volume

270,846 shs

Market Capitalization

$1.51 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.49

Meredith Cook Biography and Net Worth

What is Meredith Cook's net worth?

How old is Meredith Cook?

How do I contact Meredith Cook?

Has Meredith Cook been buying or selling shares of ANI Pharmaceuticals?

Who are ANI Pharmaceuticals' active insiders?

Are insiders buying or selling shares of ANI Pharmaceuticals?